Janssen Search
Search results
Rae Ann Cook
RAE ANN COOK GLOBAL HEAD, OPERATIONS WORLD WITHOUT DISEASE ACCELERATOR As Global Head of Operations, World Without Disease Accelerator (WWDA), Rae Ann has overall strategy realization and operational responsibility for the WWDA and the Lung Cancer ...
Disease Interception Accelerator
DIA and Type One Diabetes Presbyopia and Cataracts Perinatal Depression Oral Cavity and Oropharyngeal /Cervical Cancer Gestational Diabetes Mellitus Chronic Obstructive Pulmonary Disease Wendy Johnson and Her Hope for Disease Interception- block Oral ...
Making a Difference
Making a Difference Dec 13, 2019 VIEW STORIES read stories of how Janssen's innovations are making a difference in every corner of the globe Article Block Text: <p>Every day, our medicines help millions of people. Our commitment to providing ...
Martine Lewi, MBA, Ph.D.
Martine Lewi, MBA, Ph.D. SCIENTIFIC DIRECTOR, JCI Tine Lewi is the Scientific Director for Janssen Clinical Innovation based in Belgium. Tine is responsible for leading patient data for research initiatives and introducing novel projects in the area of ...
Dmitri Talantov, M.D.
Dmitri Talantov, M.D. SENIOR MEDICAL DIRECTOR, JCI Dr. Talantov is a medical leader with Janssen Clinical Innovation based in California. He is responsible for development of novel clinical trial models, including direct-to-patient and hybrid trials and ...
Neuropsychiatric Disorders: Expanding our focus to include the full range of psychosis spectrum disorders and mood dysregulation
Neuropsychiatric Disorders: Expanding our focus to include the full range of psychosis spectrum disorders and mood dysregulation Janssen's heritage in neuroscience began more than 60 years ago, when our namesake, Dr. Paul Janssen, developed a drug ...
First 1000 Days QuickFire Challenge
First 1000 Days QuickFire Challenge A first heartbeat. First smile. First step. The First 1000 Days of life are the most critical in human development. This unique window immensely impacts the trajectory of health. As the overall approach to healthcare ...
Cyril Titeux
CYRIL TITEUX COMPANY GROUP CHAIRMAN ASIA PACIFIC JOHNSON & JOHNSON INNOVATIVE MEDICINE Cyril Titeux is Company Group Chairman, Johnson & Johnson Innovative Medicine Asia Pacific, and a member of the Innovative Medicine Group Operating Committee ...
Partner With Our Research & Development Team
Partner With Janssen Research & Development Collaboration is in our DNA. We know where it has taken us. We know it can take us further. With a rally cry as simple as "&." Collaborations A key element of our Janssen Research & ...
Treatments for Neglected Tropical Diseases
Developing New Treatments for Neglected Tropical Diseases We Recognize the Urgent Need for Innovative Treatment Options In 2012, Johnson & Johnson signed the London Declaration on Neglected Tropical Diseases, a multilateral partnership to eliminate or ...